Macrogenics Inc. Revenue 2011–2025
Macrogenics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Macrogenics Inc. revenue for the quarter ending March 31, 2026 was 20.8 M, a 57.48% increase year-over-year.
- Macrogenics Inc. revenue for the twelve months ending March 31, 2026 was 129.0 M, a 8.48% decrease year-over-year.
- Macrogenics Inc. annual revenue for 2025 was 149.5 M, a 0.31% decrease from 2024.
- Macrogenics Inc. annual revenue for 2024 was 150.0 M, a 155.26% increase from 2023.
- Macrogenics Inc. annual revenue for 2023 was 58.7 M, a 61.33% decrease from 2022.
- Macrogenics Inc. annual revenue for 2022 was 151.9 M.
Macrogenics Inc. (MGNX) — Frequently Asked Questions
Macrogenics Inc. (MGNX) is a publicly traded US company. It has a market capitalization of $244M. In fiscal 2025 it reported revenue of $150M and net income of -$75M. Explore MGNX's stock price, financial statements, earnings history, margins and key ratios below.
What is Macrogenics Inc.'s market cap?
Macrogenics Inc. (MGNX) has a market capitalization of $244M.
What is the MGNX stock price?
MGNX trades at $3.87 (-1.02% on the day).
How much revenue does Macrogenics Inc. make?
Macrogenics Inc. reported revenue of $150M in fiscal 2025.
Is MGNX profitable?
In fiscal 2025, Macrogenics Inc. reported net income of -$75M.